Drugs / Tuberculin PPD RT 23 SSI
Tuberculin PPD RT 23 SSI
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT01241188 Comparator | Apr → Dec 2011 | tuberculosis | Statens Serum Institut | Completed | No outcome recorded |
| Phase 2/3 | NCT01779102 Comparator | Oct 2013 → Sep 2014 | tuberculosis | Statens Serum Institut | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tuberculin PPD RT 23 SSI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01779102 ↗ |
| Modality | Diagnostic / imaging agent | “Tuberculin skin testing is simple and relatively inexpensive” PMID 23691171 ↗ May 2013 |
| Route | Other | “The 2 TU Tuberculin PPD RT 23 SSI agent is administered by the Mantoux injection technique” NCT01241188 ↗ |